首页> 外文OA文献 >Renal artery denervation for the treatment of resistant hypertension. Update after Medtronic announcement that its Symplicity HTN3 study failed to meet its primary efficacy end point

【2h】

Renal artery denervation for the treatment of resistant hypertension. Update after Medtronic announcement that its Symplicity HTN3 study failed to meet its primary efficacy end point

机译：肾动脉神经支配治疗顽固性高血压。 Medtronic宣布其Symplicity HTN3研究未能达到其主要功效终点后更新

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sapoval M.; Azizi M.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Erratum: Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study (Lancet (2014) 383 (622-629)) [J] . GoodareH., VaidyaJ.S., KrumH., The Lancet . 2014,第9917期

机译：误诊：治疗高血压患者的经皮肾去神经症：对称HTN-1研究的最后3年报告（柳叶刀（2014）383（622-629））
2. Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study [J] . KrumH., SchlaichM.P., SobotkaP.A., The Lancet . 2014,第9917期

机译：治疗抗性高血压患者的经皮肾去丧失：关于合作社的最后3年的3年报告HTN-1研究
3. Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study [J] . KrumH., SchlaichM.P., SobotkaP.A., The Lancet . 2014,第9917期

机译：难治性高血压患者的经皮肾神经支配：Symplicity HTN-1研究的最后3年报告
4. A retrospective study to evaluate the efficacy of trimethoprim/sulfamethoxazole (TMP/SMX) compared to Daptomycin or Linezolid for the treatment of infections due to methicillin-resistant Staphylococcus aureus (MRSA). [D] . Poona Murari, Aparna Lakshmi. 2012

机译：回顾性研究评估甲氧苄氨嘧啶/磺胺甲恶唑（TMP / SMX）与达托霉素或利奈唑胺相比在治疗耐甲氧西林金黄色葡萄球菌（MRSA）感染中的疗效。
5. Editors choice: Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial [O] . Murray D. Esler, Michael Böhm, Horst Sievert, -1

机译：编辑选择：基于导管的肾脏去神经治疗对难治性高血压患者的治疗：SYMPLICITY HTN-2随机临床试验的结果为36个月
6. TCT-408 Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study [O] . Whitbourn Robert J., Walton Tony, Harding Scott 2014

机译：TCT-408新型同步多电极导管用于抗高血压治疗的肾动脉去神经：SYMPLICITY椎弓根先人研究的12个月更新

Renal artery denervation for the treatment of resistant hypertension. Update after Medtronic announcement that its Symplicity HTN3 study failed to meet its primary efficacy end point

著录项

引文网络

相似文献

相关主题

期刊订阅